Drug recall · July 12, 2023
Losartan Potassium Tablets recall
Why: Presence of Foreign Substance: Presence of a small piece of blue plastic embedded in the tablet.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Losartan Potassium Tablets, USP, 25 mg, 1000 film coated tablets per bottle, Rx Only, Manufactured by: Vivimed Life Sciences Private Limited, Plot No. 101, 102, 107 & 108, SIDCO Pharmaceutical Complex, Alathur, Kanchipuram- 603 110, Tamilnadu, India, NDC 64380-933-08
- Lots / codes
Lot#: 7901903A, exp. date 04/2024
- Quantity
- 2,700 HDPE Bottles
- Company
- Strides Pharma Inc., East Brunswick, NJ
- Distribution
- Nationwide in the USA.
- Initiated
- June 26, 2023 · Voluntary: Firm initiated
- Classified
- July 6, 2023
- Reported
- July 12, 2023
- Ended
- May 15, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Losartan
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.